Aktie A14PEX BIOREGENX, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen BioRegenx, Inc.

Aktien

A14PEX

US31772N1000

BRGX

Verzögert OTC Markets
Andere Börsenplätze
 17:28:31 25.06.2024 		% 5 Tage % 1. Jan.
0.018 USD -41.94% Intraday Chart für BioRegenx, Inc. -55.22% -23.40%
08.03. BioRegenx, Inc. hat die Übernahme von Findit, Inc. (OTCPK:FDIT) von WooEB, Inc., Hva Family Trust und anderen in einer Reverse-Merger-Transaktion abgeschlossen. CI
2023 Findit, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BioRegenx : Non Reliance on Previously Issued Financial Report Form 8 K
FINDIT : Management Change/Compensation - Form 8-K
BioRegenx, Inc. completed the acquisition of Findit, Inc. from WooEB, Inc., Hva Family Trust and others in a reverse merger transaction.
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Findit, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
FINDIT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Findit, Inc. Auditor Raises 'Going Concern' Doubt
FINDIT, INC. : Entry into a Material Definitive Agreement (form 8-K)
BioRegenx, Inc. entered into a Definitive Agreement to acquire Findit, Inc. in a reverse merger transaction.
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Findit : Announces Investor Update
Findit : Featured Member BioRegenx Announces Investor Update
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14PEX Aktie
  4. Nachrichten BioRegenx, Inc.
  5. Andere Sprachen